spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  SABE 

 HSMN NewsFeed - 28 Jan 2025
AI Optics Receives FDA Clearance, Increasing Patient Access to Retinal Screening
Devices Ophthalmology FDA
 HSMN NewsFeed - 6 Dec 2023
NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App
Devices FDA
 HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 10 Mar 2022
S.M.A.R.T. RADIANZ(TM) Vascular Stent System Approved for Transradial Use in the U.S.
Devices Interventional FDA
 HSMN NewsFeed - 25 Nov 2021
Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Jan 2021
DURECT Corporation Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 14 Sep 2020
Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Mar 2020
Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2020
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR(R)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Oct 2019
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIR(R) for the Treatment of Post-Surgical Pain
Biopharmaceuticals Drug Delivery Surgery FDA
 HSMN NewsFeed - 27 Jun 2019
DURECT Announces Submission to FDA of a Full Response to the POSIMIR(R) Complete Response Letter
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Jun 2019
DURECT Announces $15 Million Registered Direct Offering
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 25 Apr 2019
DURECT Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Dec 2018
Commercial Launch Plans Announced for PERSERIS(TM) (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 9 May 2018
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery Surgery Licensing
 HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Devices Oncology Dermatology Personnel
 HSMN NewsFeed - 5 Mar 2018
Philips introduces next generation of IntelliSpace Cardiovascular informatics platform at HIMSS 2018
Devices Cardiology Product Launch
 HSMN NewsFeed - 4 Jan 2018
Enterome Raises €32 Million ($38.5 Million) in a Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Sep 2017
Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2017
Matthew Gantz Appointed CEO of OxThera
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2017
DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR(R)
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2017
Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen (IONIS-TTR Rx) Meets Both Primary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 16 Feb 2017
Denovo Biopharma plans to launch a Global Phase 3 Trial of DB102 (Enzastaurin) in Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Nov 2016
OxThera Raises EUR 32 Million to Complete Development of Oxabact(R) for Treatment of Primary Hyperoxaluria
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Oct 2016
Avita Medical's ReCell(R) devices now treating burns in South Africa and Benelux
Regenerative Medicine Distribution
 HSMN NewsFeed - 15 Mar 2016
Dutch Medical Center Begins Radiosurgery Treatments with Elekta's Leksell Gamma Knife Icon
Devices Oncology Neurosurgery
 HSMN NewsFeed - 27 Jan 2016
InnFocus MicroShunt(R) 3-Year Results of a Long Term Clinical Trial Show Long Lasting IOP Reduction
Devices Ophthalmology
 HSMN NewsFeed - 10 Nov 2015
FDA Approves InnFocus Glaucoma Study Expansion
Devices Ophthalmology FDA
 HSMN NewsFeed - 22 Sep 2015
Invuity(R) Introduces Eiberg(TM) Illuminated Retractor System With Integrated Intelligent Photonics(TM) To Orthopedic Market
Devices Surgery Product Launch
 HSMN NewsFeed - 19 Nov 2014
Cordis Corporation Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT(R) System Data
Devices Interventional
 HSMN NewsFeed - 30 Oct 2014
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 23 Jun 2014
ARIAD Announces Three Key Appointments to Its Global Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2014
Enterome Raises €10 million in Series B Fund Raising
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Apr 2014
OxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2014
Beth Israel Deaconess Medical Center Uses Carestream’s DRX Systems to Enhance Diagnosis, Treatment of Critical Care Patients
Devices Radiology
 HSMN NewsFeed - 7 Jan 2014
Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 31 Dec 2013
George S. Zorich Named Chief Executive Officer of Agilis Biotherapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 27 Sep 2013
DURECT Announces Changes to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Jul 2013
Meditope Biosciences Raises $3.6M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Jun 2013
Toshiba Cardiac Ultrasound Improves Visualization, Diagnostic Accuracy
Devices Cardiology Radiology
 HSMN NewsFeed - 20 Jun 2013
DURECT Announces FDA Acceptance of New Drug Application (NDA) Submission for POSIDUR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 27 Feb 2013
Claret Medical, Inc. Announces CE Mark Approval of Montage 2(TM) and Live Case Debut During JIM 2013
Devices Interventional Regulatory
 HSMN NewsFeed - 19 Sep 2012
OxThera Raises Capital for Further Clinical Development of Oxabact(R)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jul 2012
Addition of Tarceva(R) (erlotinib) to Nexavar(R) (sorafenib) did not Provide Additional Benefit to Patients with Unresectable Liver Cancer Versus Nexavar alone in Phase 3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jul 2012
Sandoz completes acquisition of Fougera Pharmaceuticals, positioning Sandoz as #1 in generic dermatology globally
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 7 Jun 2012
OxThera Resumes Clinical Development of Hyperoxaluria Therapy
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2012
KYTHERA Biopharmaceuticals Appoints Industry Veteran Elisabeth Sandoval as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Apr 2011
Diamyd Medical Replaces CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2011
Baxter Introduces OLIMEL in Canada as the First Triple-Chamber Bag for Nutrition
Devices
 HSMN NewsFeed - 8 Dec 2010
Myriad Acquires Novel Technology From Melanoma Diagnostics
Diagnostics Oncology Acquisitions
 HSMN NewsFeed - 19 Nov 2010
Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology Regulatory
 HSMN NewsFeed - 4 Nov 2010
Bausch & Lomb Surgical Strengthens Management Team With Three New Appointments
Devices Ophthalmology Personnel
 HSMN NewsFeed - 4 Nov 2010
BIOTRONIK Announces First Patient Enrollment in the BIOLUX P-I Clinical Study Investigating Drug-Eluting Balloon Therapy for Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 21 Oct 2010
Toshiba Ultrasound Systems Improve Workflow at University Hospitals Case Medical Center
Devices
 HSMN NewsFeed - 23 Aug 2010
First European Incisionless Procedure to 'Reverse Weight Gain After Gastric Bypass Surgery' Takes Place in UK
Devices
 HSMN NewsFeed - 19 Jul 2010
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
Devices
 HSMN NewsFeed - 19 Apr 2010
Covidien Announces Innovation: Delivered Mobile Surgical Tour
Devices Surgery
 HSMN NewsFeed - 26 Mar 2010
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Mar 2010
Diamyd Medical: Diamyd US Phase III Study Well under Way
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jan 2010
DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 20 May 2009
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 May 2009
Biovail Announces Acquisition of U.S. Rights to Wellbutrin XL
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 May 2009
Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin
Biopharmaceuticals Licensing Neurology
 HSMN NewsFeed - 27 Feb 2009
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Aug 2008
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2008
Biovail Strengthens Leadership Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Mar 2008
Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 14 Mar 2008
Diamyd Medical: Diamyd Gets Authorization to Begin Phase III Study in the US
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 15 Jan 2008
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Jan 2008
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Biopharmaceuticals Distribution
 HSMN NewsFeed - 12 Dec 2007
Elisabeth Lindner New President and CEO of Diamyd Medical
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2007
Biovail Announces Settlement Agreement Related to Cardizem(R) LA
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Nov 2007
Biovail Enters into Development Agreement
Biopharmaceuticals
 HSMN NewsFeed - 5 Nov 2007
New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Nov 2007
Amira Pharmaceuticals Appoints First Vice President of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2007
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Sep 2007
Integra LifeSciences Launches Bone-Cutting Selector SaberTip At 2007 Congress of Neurological Surgeons Meeting
Devices Neurosurgery
 HSMN NewsFeed - 20 Jul 2007
Biovail Provides Update on BVF-033
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 16 Jul 2007
Hanger Orthopedic Group, Inc. Announces a Commercialization Agreement Between Its Subsidiary, Innovative Neurotronics, and Teijin Limited for the WalkAide System in the Japanese Market
Devices Licensing
 HSMN NewsFeed - 29 May 2007
DRAXIS Appoints Bruce DeChambre to Head Business Development for Contract Manufacturing Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2007
Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 May 2007
Biovail Chairman Eugene Melnyk Announces Retirement
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2007
Biovail Announces Comprehensive Settlement Related to Wellbutrin XL(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Feb 2007
Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 9 Feb 2007
Medtronic Begins First-Ever Study to Evaluate New Pacemaker System Designed for Safe Use with MRI Machines
Devices Cardiology Radiology
 HSMN NewsFeed - 29 Jan 2007
DURECT Signs POSIDUR(TM) Manufacturing Agreement with Hospira
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Biovail Provides Strategy Update
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 6 Dec 2006
Biovail Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2006
DURECT and Nycomed Sign $202 Million Agreement to Develop and Commercialize POSIDUR(TM) in Europe and Other Select Countries
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2006
Specialty Laboratories Launches First Genomic Clinical Laboratory Test to Predict Progression to Liver Fibrosis for Hepatitis C Virus Patients
Diagnostics
 HSMN NewsFeed - 6 Sep 2006
RoundTable Healthcare Partners Acquires Aspen Surgical Products, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2006
Hanger Orthopedic Group, Inc. Announces the Acquisition of Temple Medical, Inc.
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 24 May 2006
AnorMED President and CEO Michael Abrams steps down
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 61

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 61 additional stories matching:
SABE
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.